These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37977318)

  • 1. Epigallocatechin-3-gallate maintains Th1/Th2 response balance and mitigates type-1 autoimmune diabetes induced by streptozotocin through promoting the effect of bone-marrow-derived mesenchymal stem cells.
    Ahmadzadeh F; Esmaili M; Ehsan Enderami S; Ghasemi M; Azadeh H; Abediankenari S
    Gene; 2024 Feb; 894():148003. PubMed ID: 37977318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H; Hashemi SM; Soleimani M; Mohammadi J; Tajik N
    J Diabetes Res; 2015; 2015():878535. PubMed ID: 25893202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vivo and ex vivo pre-treated bone marrow-derived mesenchymal stem cells with resveratrol in streptozotocin-induced type 1 diabetic rats.
    Khalil SG; Younis NN; Shaheen MA; Hammad SK; Elswefy SE
    J Pharm Pharmacol; 2023 Sep; 75(9):1186-1197. PubMed ID: 37177978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice.
    Song EK; Hur H; Han MK
    Arch Pharm Res; 2003 Jul; 26(7):559-63. PubMed ID: 12934649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes.
    Nojehdehi S; Soudi S; Hesampour A; Rasouli S; Soleimani M; Hashemi SM
    J Cell Biochem; 2018 Nov; 119(11):9433-9443. PubMed ID: 30074271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-derived insulin-producing cells modulate Th1 immune responses and induce IL-10 in streptozotocin-induced mouse model of pancreatic insulitis.
    Daryabor G; Shiri EH; Amirghofran Z; Kamali-Sarvestani E
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):376-382. PubMed ID: 33879406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
    Bao Y; Zhao Z; Gao H
    Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate augments therapeutic effects of mesenchymal stem cells in skin wound healing.
    Li M; Xu J; Shi T; Yu H; Bi J; Chen G
    Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1115-1124. PubMed ID: 27557877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats.
    Ahmed OM; Saleh AS; Ahmed EA; Ghoneim MM; Ebrahim HA; Abdelgawad MA; Abdel-Gabbar M
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors.
    Bell GI; Meschino MT; Hughes-Large JM; Broughton HC; Xenocostas A; Hess DA
    Stem Cells Dev; 2012 Jul; 21(11):1863-76. PubMed ID: 22309189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate Protects against Hydrogen Peroxide-Induced Inhibition of Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
    Wang D; Wang Y; Xu S; Wang F; Wang B; Han K; Sun D; Li L
    Stem Cells Int; 2016; 2016():7532798. PubMed ID: 26977159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of mouse adipose- and bone marrow mesenchymal stem cells in diabetic model with critical limb ischemia.
    Asadi-Yousefabad SL; Nammian P; Sheikhha MH; Tabei SMB; Daneshi S; Nikukar H; Lotfi M; Razban V
    Cell Tissue Bank; 2022 Dec; 23(4):923-936. PubMed ID: 35590084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.